Prospective real-life single-center study on the efficacy and safety of ofatumumab for the treatment of highly active multiple sclerosis

被引：0
|
作者：
Moiola, Lucia [1 ]
Gattuso, Irene [1 ]
Guerrieri, Simone [1 ]
Genchi, Angela [1 ]
Nozzolillo, Agostino [1 ]
Zanetta, Chiara [1 ]
Ferre, Laura [1 ]
Martire, Sofia [1 ]
Esposito, Federica [1 ]
Zaccone, Tiziana [1 ]
Rocca, Maria Assunta [2 ]
Filippi, Massimo [3 ]
机构：
[1] San Raffaele Hosp Milan, IRCCS, Neurol, Milan, Italy
[2] Univ Vita Salute San Raffaele, Neuroimaging Res Unit, Neurol Unit, San Raffaele Hosp, Milan, Italy
[3] Univ Vita Salute San Raffaele, Hosp San Raffaele, Neurol Unit, Neurorehabiitat Unit,Neuroimaging Res Unit,Neurop, Milan Italy, Italy
来源：
MULTIPLE SCLEROSIS JOURNAL | 2024年 / 30卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P811/2444
引用
收藏
页码：622 / 622
页数：1
相关论文
共 50 条
  • [1] REALMS Study: Single-center retrospective observational single-center study of alemtuzumab (Lemtrada®) treatment in a Spanish cohort of multiple sclerosis patients under real-life conditions
    Eichau, S.
    Lopez-Ruiz, R.
    Dotor, J.
    Ruiz de Arcos, M.
    Ruiz-Pena, J. L.
    Navarro-Mascarell, G.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 716 - 716
  • [2] REAL-LIFE EFFICACY AND SAFETY OF IXEKIZUMAB IN A COHORT OF PATIENTS WITH PSORIATIC ARTHRITIS: A SINGLE-CENTER RETROSPECTIVE STUDY
    Bellis, E.
    Donzella, D.
    Crepaldi, G.
    Data, V.
    Gammino, M.
    Guardo, V.
    Lomater, C.
    Marucco, E.
    Saracco, M.
    Iagnocco, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1790 - 1790
  • [3] Real-life effectiveness and safety of secukinumab in axial spondyloarthritis: a single-center study
    Sun Yuankai
    Wang Jiajia
    Qiu Yulu
    Lin Shiyu
    Wang Fang
    Tan Wenfeng
    中华医学杂志英文版, 2022, 135 (21)
  • [4] Real-life effectiveness and safety of secukinumab in axial spondyloarthritis: a single-center study
    Sun, Yuankai
    Wang, Jiajia
    Qiu, Yulu
    Lin, Shiyu
    Wang, Fang
    Tan, Wenfeng
    CHINESE MEDICAL JOURNAL, 2022, 135 (21) : 2623 - 2624
  • [5] Real-World Alemtuzumab Efficacy and Safety in a Multiple Sclerosis Patient Population: A Single-Center Cohort Study
    Kalligianni-Sofikiti, M. -E.
    Mastorodemos, V.
    Mitsias, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 923 - 923
  • [6] Efficacy and safety of alemtuzumab in a real-life cohort of patients with multiple sclerosis
    Jessica Frau
    Giancarlo Coghe
    Lorena Lorefice
    Giuseppe Fenu
    Luigina Musu
    Eleonora Cocco
    Journal of Neurology, 2019, 266 : 1405 - 1411
  • [7] Efficacy and safety of alemtuzumab in a real-life cohort of patients with multiple sclerosis
    Frau, Jessica
    Coghe, Giancarlo
    Lorefice, Lorena
    Fenu, Giuseppe
    Musu, Luigina
    Cocco, Eleonora
    JOURNAL OF NEUROLOGY, 2019, 266 (06) : 1405 - 1411
  • [8] Efficacy and Safety of Imatinib Treatment in Elderly Patients With Chronic Myeloid Leukemia: Real-Life Data and a Single-Center Experience
    Eskazan, Ahmet Emre
    Ozmen, Deniz
    Oztas, Mert
    Bektas, Fatih
    Bayraktar, Esref Alperen
    Sadri, Sevil
    Keskin, Dilek
    Yurttas, Nurgul Ozgur
    Elverdi, Tugrul
    Salihoglu, Ayse
    Ar, Muhlis Cem
    Ongoren, Seniz
    Baslar, Zafer
    Aydin, Yildiz
    Soysal, Teoman
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (08): : 549 - 557
  • [9] Rivaroxaban for the treatment of venous thromboembolism in real life A single-center prospective study
    Demelo-Rodriguez, Pablo
    Galeano-Valle, Francisco
    Garcia-Fernandez-Bravo, Irene
    Piqueras-Ruiz, Sandra
    Alvarez-Sala-Walther, Luis
    del Toro-Cervera, Jorge
    MEDICINE, 2019, 98 (03)
  • [10] Real-life efficacy and safety of biologic treatment in patients with moderate to severe psoriasis and previous diagnosis of a malignant tumor: Single-center descriptive study
    Duran Romero, Antonio Jose
    Fernandez Freire, Lourdes Rodriguez
    Sendin Martin, Mercedes
    Ortiz Alvarez, Juan
    Hernandez Rodriguez, Juan Carlos
    Conejo-Mir Sanchez, Julian
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB198 - AB198
12345